Abstract
Fine needle aspiration and small tissue biopsies have become a primary modality to achieve a definitive diagnosis of a mass-like lesion of the lung and mediastinum. This chapter delineated cytologic and histologic features of common and rare neoplastic and nonneoplastic mass-like lesions of the lung and mediastinum. The utilities and pitfalls of commonly used diagnostic immunohistochemical (IHC) stains, such as TTF1, Napsin A, p40 and CK5/6, and small diagnostic IHC panels, were described. Multiple challenging and yet practical cases at the end of the chapter were used to reemphasize important points illustrated throughout the chapter.
You have full access to this open access chapter, Download chapter PDF
Similar content being viewed by others
Keywords
- Lung
- Mediastinum
- Thymus
- Adenocarcinoma (Lepidic adenocarcinoma)
- Acinar adenocarcinoma
- Papillary adenocarcinoma
- Micropapillary adenocarcinoma
- Solid adenocarcinoma
- Invasive mucinous adenocarcinoma
- Mixed invasive mucinous and nonmucinous adenocarcinoma
- Colloid adenocarcinoma
- Fetal adenocarcinoma
- Enteric adenocarcinoma
- Minimally invasive adenocarcinoma
- Nonmucinous
- Mucinous
- Preinvasive lesions
- Atypical adenomatous hyperplasia
- Adenocarcinoma in situ (nonmucinous mucinous)
- Squamous cell carcinoma
- Keratinizing squamous cell carcinoma
- Nonkeratinizing squamous cell carcinoma
- Basaloid squamous cell carcinoma
- Preinvasive lesion
- Squamous cell carcinoma in situ
- Neuroendocrine tumors
- Small cell carcinoma
- Combined small cell carcinoma
- Large cell neuroendocrine carcinoma
- Combined large cell neuroendocrine carcinoma
- Carcinoid tumors
- Typical carcinoid tumor
- Atypical carcinoid tumor
- Preinvasive lesion
- Diffuse idiopathic pulmonary
- Neuroendocrine cell hyperplasia
- Large cell carcinoma
- Adenosquamous carcinoma
- Sarcomatoid carcinomas
- Pleomorphic carcinoma
- Spindle cell carcinoma
- Giant cell carcinoma
- Carcinosarcoma
- Pulmonary blastoma
- Other and unclassified carcinomas
- Lymphoepithelioma-like carcinoma
- Nuclear protein in testis (NUT) carcinoma
- Salivary gland-like tumors
- Mucoepidermoid carcinoma
- Adenoid cystic carcinoma
- Epithelial-myoepithelial carcinoma
- Pleomorphic adenoma
- Papillomas
- Squamous cell papilloma (exophitic inverted)
- Glandular papilloma
- Mixed squamous and glandular papilloma
- Adenomas
- Sclerosing pneumocytoma
- Alveolar adenoma
- Papillary adenoma
- Mucinous cystadenoma
- Mucous gland adenoma
- Pulmonary hamartoma
- Chondroma
- PEComatous tumors
- Lymphangioleiomyomatosis
- PEComa (benign)
- Clear cell tumor
- PEComa (malignant)
- Congenital peribronchial myofibroblastic tumor
- Epithelial hemangioendothelioma
- Pleuropulmonary blastoma
- Synovial sarcoma
- Pulmonary artery intimal sarcoma
- Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation
- Myoepithelial tumors
- Myoepithelioma
- Diffuse malignant mesothelioma
- Epithelioid mesothelioma
- Sarcomatoid mesothelioma
- Desmoplastic mesothelioma
- Biphasic mesothelioma
- Localized malignant mesothelioma
- Epithelioid mesothelioma
- Sarcomatoid mesothelioma
- Biphasic mesothelioma
- Well-differentiated papillary mesothelioma
- Adenomatoid tumor
- Epithelioid hemangioendothelioma
- Angiosarcoma
- Synovial sarcoma
- Solitary fibrous tumor
- Malignant solitary fibrous tumor
- Desmoid-type fibromatosis
- Calcifying fibrous tumor
- Desmoplastic round cell tumor
- Thymoma
- Lymphoma
- Sarcoma
- Germ cell tumor
- Metastatic carcinoma
- Candida species
- Aspergillus species
- Phycomycosis (such as mucormycosis)
- Cryptococcus neoformans
- Histoplasma capsulatum
- Blastomyces dermatitidis
- Coccidioides immitis
- Pneumocystis carinii
- TTF1
- Napsin a
- Calretinin
- WT-1
- CK5/6
- p40
- p63
- MIB-1 (Ki67)
- Chromogranin
- Synaptophysin
- CD56
- MOC31
- PAX8
- CD5
- CD117
- GLUT1
- p53
- p16
- TdT
-
The concept of personalized medicine and the remarkable advances in lung cancer genetics and therapy in the past decade have changed lung pathology practice dramatically.
-
The 2015 World Health Organization (WHO) classification of tumors of the lung specifies that immunohistochemistry is required for lung cancer diagnosis, not only for small biopsies and fine needle aspiration (FNA) specimens but also for certain resected specimens such as solid adenocarcinoma (ADC), nonkeratinizing squamous cell carcinom a, large cell carcinoma , neuroendocrine tumors , and sarcomatoid carcinomas .
-
New criteria and terminology for the diagnosis of lung cancer based on small biopsies and cytology are proposed in the 2015 WHO classification and are summarized in Tables 6.1 and 6.2.
-
The role of cytopathologists has expanded to not only making a specific diagnosis, including histopathological subtyping of tumors, but also to thoughtfully utilizing the limited material for necessary genetic studies to help personalize treatment strategies for advanced lung cancer patients.
-
Thyroid transcription factor 1 (TTF1 ) and napsin A are accepted markers for ADC differentiation; p40 is reported to be the most specific and sensitive marker for squamous cell differentiation. A reasonable recommendation is that, when immunohistochemistry is deemed necessary, at least one antibody each for squamous and glandular differentiation, but no more than two antibodies, should be used for an initial workup (e.g., TTF1 and p40 or p63 ). Thus a limited panel of TTF1 and p40 (or p63) is suggested for subtyping the tumor to preserve tissue for molecular testing.
-
Molecular testing for epithelial growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) rearrangement is recommended in tumors classified as ADC and in cases where an ADC component cannot be excluded.
-
When evaluating a computed tomography (CT)-guided FNA of a lung lesion in the periphery, mesothelial cells are frequently seen on smears; reactive mesothelial cells may mimic carcinoma, and caution should be taken.
-
Diagnosis of ADC with a lepidic growth pattern can be challenging in FNA specimens. Both quality (degree of atypia) and quantity (groups of atypical cells) need to be considered. In a typical case of ADC with a lepidic growth pattern, the smears tend to be very cellular, containing many groups of atypical epithelial cells. In contrast, in a reactive condition, such as pulmonary infarction, atypical reactive pneumocytes are usually less numerous.
-
In mucinous ADC with a lepidic growth pattern, the neoplastic epithelial cells may mimic pulmonary macrophages. Features such as a mucinous background, cytoplasmic mucin/vacuoles, eccentrically located nuclei, and more abundant cytoplasm are helpful in reaching a correct diagnosis.
-
Basaloid squamous cell carcinoma may mimic small cell carcinoma ; therefore, cellblock preparation in conjunction with immunostains will be helpful.
-
Infection such as aspergillosis may result in squamous cells with significant cytological atypia; therefore, infectious etiologies should be excluded before a diagnosis of well-differentiated squamous cell carcinoma is rendered.
-
A lesion from the mediastinum should be considered if cytological features do not fit the description of a typical “lung lesion.”
-
Thymoma is rare in young patients and children. In lymphocyte-dominant thymoma, the main component of the aspirate may contain cortical thymocytes with expression of terminal deoxynucleotidyl transferase (TdT ) and cluster of differentiation (CD)99; therefore, caution should be taken to avoid misdiagnosing it as a lymphoblastic lymphoma.
-
Thymic neuroendocrine neoplasm may mimic an epithelial-dominant thymoma; therefore, immunohistochemistry should be performed in cases with equivocal features.
Lung
Tables 6.1 and 6.2 summarize new criteria and terminology for the diagnosis of lung cancer based on small biopsies and cytology from the 2015 WHO classification .
Normal Cytology
Upper Respiratory Tract
Lower Respiratory Tract
-
Trachea and bronchi
-
Terminal bronchioles
-
Non-ciliated cuboidal/columnar cells (Clara cells)
-
Alveoli
-
Type I and II pneumocytes
-
Alveolar macrophages , see Fig. 6.5.
-
Respiratory Infections
Viral Infections
Specific viral infections, such as herpes simplex (Fig. 6.6) and cytomegalovirus (Fig. 6.7), can cause significant cytological changes that may mimic a malignant process. The diagnosis can be confirmed by immunoperoxidase studies.
Severe acute respiratory syndrome (SARS ) caused by a novel coronavirus (SARS-CoV ) became a worldwide outbreak in 2003, affecting more than 8000 patients, with a fatality rate of 9.2%. SARS-CoV belongs to a family of large, positive, single-stranded ribonucleic acid (RNA) viruses. The key pathologic finding is diffuse alveolar damage (DAD ) . Depending on different phases in the disease progression, the composition of inflammatory cells may vary; however, macrophages (including multinucleated forms) and lymphocytes usually predominate. Other pathologic findings, such as fibrosis, prominent vascular injury, hemophagocytosis, squamous metaplasia, apoptosis, and atypical pneumocytes, including multinucleated giant pneumocytes with irregularly distributed nuclei or pneumocytes with large atypical nuclei, prominent eosinophilic nucleoli, and granular amphophilic cytoplasm, were reported. Ancillary tests, such as in situ hybridization, immunohistochemistry, viral isolation, or reverse transcription polymerase chain reaction (RT-PCR), are necessary to confirm the diagnosis. Representative images are shown in Fig. 6.8a, b.
Fungal Infections
FNA is a useful means of diagnosing pulmonary fungal infection, which should be suspected whenever there is granulomatous inflammation. Silver or periodic acid-Schiff (PAS) stains are used on cellblock sections.
The common fungal infections include (1) Candida species ; (2) Aspergillus species , Fig. 6.9; (3) phycomycosis (such as mucormycosis ); (4) Cryptococcus neoformans , Fig. 6.10a–d; (5) Histoplasma capsulatum , Fig. 6.11a, b; (6) Blastomyces dermatitidis , Fig. 6.12a, b; (7) Coccidioides immitis , Fig. 6.13a, b; and (8) Pneumocystis carinii , Fig. 6.14a–c. The morphological features of these fungi are summarized in Table 6.3.
Strongyloidiasis
Pulmonary strongyloidiasis affects immunocompetent and, more commonly, immunosuppressed persons presenting with pneumonitis with hemoptysis. The etiological agent is the nematode. Strongyloides stercoralis in sputum is shown in Fig. 6.15.
Bacterial Infection
Infection by Mycobacterium tuberculosis is often a granulomatous inflammation containing clusters of epithelioid histiocytes, lymphocytes, and Langhans giant cells, with or without necrosis. In immunocompromised patients there may be abundant acid-fast organisms without obvious granulomatous inflammation.
Acquired immunodeficiency syndrome (AIDS) patients are especially susceptible to Mycobacterium avium-intracellulare , an acid-fast organism producing negative images on Romanowsky stain. Special stains on cellblock section are particularly helpful.
Nocardia , a weakly acid-fast filamentous organism, often infects immunocompromised patients, producing cavitary nodules on radiographs, which may mimic a neoplastic process .
Other Types of Granulomatous Inflammation
Sarcoidosis
Key Clinical Features
-
Sarcoidosis is characterized by non-caseating granulomas in many organs, most commonly the lung.
Key Radiological Features
-
Chest x-ray: bilateral hilar adenopathy is a classic finding; variable lung parenchyma changes, from normal, diffuse reticular, or ground glass opacities, nodular consolidation or cystic scarring.
-
CT and positron emission tomography (PET) scan can also be used.
Cytological Features
-
Aggregates of epithelioid histiocytes, with or without Schaumann and asteroid bodies
-
Multinucleated giant cells and lymphocytes
Differential Diagnosis
An essential part of the diagnosis of sarcoidosis is the exclusion of alternative possibilities:
-
Granulomas caused by infectious agents, such as mycobacterial infection and fungal infection
-
Drug-induced, hypersensitivity pneumonitis, or foreign body granulomatosis
-
Pulmonary histiocytic disorders
-
Granulomatous disorders associated with vascular inflammation such as Wegener granulomatosis and Churg-Strauss syndrome
Wegener Granulomatosis
Key Clinical Features
-
Wegener granulomatosis is characterized by necrotizing vasculitis and may present as a lung mass with or without involvement of nasal passages and kidneys.
Key Radiological Features
-
Multiple pulmonary nodules on imaging
Cytological Features
-
Neutrophils, giant cells, necrotic collagen, and epithelioid histiocytes
-
The findings are nonspecific; therefore, serologic studies are necessary.
Differential Diagnosis
-
Granulomatous inflammations
-
Metastatic diseases
-
Non-Hodgkin lymphomas
Nodular Pulmonary Amyloidosis (Amyloid Tumor)
Key Clinical Features
-
Amyloid deposits in the lung, forming discrete nodular masses
Key Radiological Features
-
Discrete pulmonary nodules/masses (amyloidomas) on imaging
Cytological Features
-
Irregular, waxy, amorphous, hypocellular material with a scalloped, occasionally cracked appearance, which is blue-green on Papanicolaou (Pap) stain and shows apple-green dichroism under polarized light after staining with Congo red
Differential Diagnosis
-
Granulomatous inflammations
-
Metastatic diseases
-
Non-Hodgkin lymphomas
Pulmonary Neoplasms
The 2015 WHO Classification of Tumors of the Lung, Pleura, Thymus and Heart has been published recently. There are numerous important changes in the classification of lung tumors, as summarized in Table 6.4.
Representative Benign Neoplasms of the Lung
Pulmonary Hamartoma
Key Clinical Features
-
The most common benign pulmonary neoplasm
-
Usually asymptomatic, incidental finding
-
Common in males, especially elderly men
Key Radiological Features
-
Chest x-ray: solitary or multiple discrete, round, golf ball-like lesions (“coin lesions”), usually peripherally located, about 10% endobronchial
Cytological Features
-
A mixture of mesenchymal and epithelial elements
-
Immature fibromyxoid matrix
-
Mature cartilage with chondrocytes in lacunae
-
Benign glandular cells
-
Adipocytes
-
Representative images are shown in Fig. 6.16a, b.
Differential Diagnosis
-
Epithelial malignancy
Histology
-
Round to multilobulated, well-circumscribed tumor nodules composed of mesenchymal tissues, including chondroid or chondromyxoid tissue, fat, connective tissue, smooth muscle, and bone in various proportions, intermixed with clefts of respiratory epithelial cells
-
Chondromyxoid tissue usually predominates.
-
Representative images are shown in Fig. 6.16c, d.
Immunohistochemistry
-
Immunohistochemistry is usually not necessary for diagnosis.
-
Pulmonary hamartomas have a high frequency of translocation t(3;12)(q27–28;q14–15) leading to a gene fusion of the high mobility group protein gene AT-hook 2 (HMGA2) and the lipoma preferred partner (LPP) gene.
Inflammatory Myofibroblastic Tumor
Key Clinical Features
-
Most often young patients, under the age of 40
-
Male = female
-
The most common endobronchial mesenchymal lesion in childhood
Key Radiological Features
-
Chest x-ray: a peripheral, discrete, solitary nodule. If endobronchial location, post-obstructive pneumonia and atelectasis may be evident.
Cytological Features
-
Spindle cells
-
Storiform pattern
-
Polymorphous inflammatory cells
-
Minimal to no necrosis
Differential Diagnosis
-
Sarcoma
-
Mesothelioma
-
Solitary fibrous tumor
Histology
-
Composed of a mixture of spindle cells and obscuring inflammatory cell infiltrates, including lymphocytes, plasma cells, and histiocytes.
-
Touton giant cells are often seen.
-
The spindle cells contain oval nuclei with a fine chromatin pattern, inconspicuous nucleoli, and abundant bipolar lightly eosinophilic cytoplasm arranged in fascicles or a storiform architecture.
-
Representative images are illustrated in Fig. 6.17a, b.
Immunohistochemistry
-
Positive for vimentin, smooth muscle actin (SMA), and rarely to desmin
-
Negative for myogenin, myoglobin, CD117 , and S100 protein
-
Focal cytokeratin (CK) positivity was reported in 1/3 of cases, likely due to alveolar entrapment.
-
Anaplastic lymphoma kinase 1 (ALK1) expression was noted in 40% of cases.
-
p53 is negative; however, positivity is associated with recurrence and malignant transformation.
-
Representative images are illustrated in Fig. 6.17c, d.
Representative Malignant Neoplasms of the Lung
Squamous Cell Carcinoma
Squamous cell carcinomas are malignant tumors that either morphologically show squamous cell differentiation (keratinization and/or intercellular bridges) or are morphologically undifferentiated non-small cell carcinomas but show squamous cell differentiation immunohistochemically. The 2015 WHO classifications of tumors of the lung reclassified squamous cell carcinomas into keratinizing, nonkeratinizing, and basaloid subtypes. The nonkeratinizing tumors require immunohistochemical proof of squamous differentiation.
Key Clinical Features
-
About 20% of all pulmonary malignancies
-
Clinical presentation is similar to other non-small cell carcinomas.
Key Radiological Features
-
Usually a central mass with cavitation and post-obstructive pneumonia
Cytological Features
Keratinizing squamous cell carcinoma :
-
Abundant dyshesive cells with dense cytoplasm, may be orangeophilic
-
Polygonal, rounded, or elongated cells
-
Tadpole or fiber-like cells
-
Pleomorphic, pyknotic nuclei with obscured nucleoli and chromatin detail
-
Anucleated cells and twisted keratin strands (Herxheimer spirals)
-
Representative images are shown in Fig. 6.18a–d.
Nonkeratinizing or basaloid squamous cell carcinoma :
-
Cohesive groups of cells with larger nuclei and coarsely granular chromatin
-
Cyanophilic cytoplasm on Pap stain
-
Rare or no keratinization
-
Representative images are shown in Fig. 6.19a–f.
Differential Diagnosis
-
Squamous metaplasia
-
Cavitary infection
-
Pemphigus vulgaris
-
Radiation/chemotherapy effect
-
Other non-small cell carcinoma
-
Small cell carcinoma
-
Upper airway cancer contamination
Histology
-
Three subtypes of squamous cell carcinoma in the 2015 WHO classification of tumors of the lung: keratinizing, nonkeratinizing, and basaloid subtypes:
-
1.
Keratinizing squamous cell carcinomas exhibit recognizable keratinization, keratin pearls, and/or intercellular bridges, as illustrated in Fig. 6.20a, b.
-
2.
Nonkeratinizing squamous cell carcinomas are without recognizable keratinization, keratin pearls, or intercellular bridges, as illustrated in Fig. 6.20c.
-
3.
Basaloid squamous cell carcinomas are tumors with a basaloid component in greater than 50% of the tumor, regardless of the presence of any keratinization, as illustrated in Fig. 6.20d.
-
1.
Immunohistochemistry
-
Immunohistochemistry is required for the diagnosis of nonkeratinizing squamous cell carcinomas.
-
Squamous cell carcinomas express p40 , p63 , and CK5/6 .
-
TTF1 is usually negative in keratinizing squamous cell carcinomas , may be weakly focally positive in nonkeratinizing squamous cell carcinomas.
-
Representative images are illustrated in Fig. 6.21a–d.
-
Squamous cell carcinomas of lung are characterized by complex genomic alterations, frequently involving the following pathways:
-
1.
Cyclin-dependent kinase inhibitor 2A/retinoblastoma 1/nuclear factor, erythroid 2 like 2/Kelch-like ECH-associated protein 1/cullin 3 (CDKN2A/RB1, NFE2L2/KEAP1/CUL3)
-
2.
Phosphoinositide 3-kinase/protein kinase B (PI3K/AKT)
-
3.
Sex-determining region Y box 2/tumor protein 63/Notch (Drosophila) homolog 1(SOX2/TP63/NOTCH1)
-
1.
Gene copy number alterations involving chromosomes 3q (SOX2, TP63), 7p (EGFR), and 8p (fibroblast growth factor receptor 1 [FGFR1]) are characteristic. Almost all tumors display somatic mutation of tumor protein 53 (TP53). Deletion of chromosome 9p (CDKN2A) was observed in 72% of cases .
Adenocarcinoma (ADC)
Key Clinical Features
-
The most common primary pulmonary malignancy, accounting for about 40% of cases.
-
Mortality and incidence rates have generally been highest in high-income countries but are now declining, especially in younger males and females.
-
Has been more common in men than in women, but has begun to converge.
Key Radiological Features
-
Usually a solitary peripheral nodule/mass
Cytological Features
-
Cohesive, three-dimensional groups.
-
Eccentric, irregular nuclei with granular chromatin, and prominent nucleoli.
-
Transparent, foamy cytoplasm, may have secretory vacuoles.
-
Invasive mucinous ADC: high cellularity, sheets and three-dimensional groups of relatively uniform cells, nuclear enlargement and irregular contour, and nucleoli. May have pseudoinclusions, psammoma bodies, and nuclear grooves/clearing.
-
Poorly differentiated ADC: cohesive groups of overtly malignant cells with nuclear pleomorphism, nuclear membrane irregularity, and coarse chromatin pattern; cytoplasmic mucin is inconspicuous.
-
Representative images are shown in Fig. 6.22a–h.
Differential Diagnosis
-
Metastatic ADC
-
Reactive/reparative changes
-
Goblet cell hyperplasia
-
Granulomatous inflammation
-
Vegetable cells
Histology
-
In 2011, the new International Association for the Study of Lung Cancer (IASLC) /American Thoracic Society (ATS) /European Respiratory Society (ERS) classification of lung ADC proposed significant changes to the 2004 WHO classification for resected tumors:
-
1.
Discontinuing the terms bronchioloalveolar carcinoma (BAC) and mixed subtype ADC
-
2.
Adding adenocarcinoma in situ (AIS) as a preinvasive lesion to join atypical adenomatous hyperplasia
-
3.
Adding minimally invasive adenocarcinoma (MIA)
-
4.
Classifying invasive ADCs according to the predominant subtype after comprehensive histologic subtyping in 5% increments
-
5.
Using of “lepidic” to describe a noninvasive component (previously BAC) as part of an invasive ADC
-
6.
Replacing mucinous BAC with invasive mucinous ADC excluding tumors that meet the criteria for AIS or MIA
-
7.
Discontinuing the subtypes of clear cell and signet ring ADC
-
8.
Discontinuing the term mucinous cystadenocarcinoma and including these under the category of colloid ADC
-
1.
-
In the 2015 WHO classification, large cell carcinomas with expression of TTF1 and/or napsin A are reclassified as solid ADCs even if mucin is absent. The solid ADC must be distinguished from squamous cell carcinomas and large cell carcinomas by the identification of at least two high-power fields with five or more cells showing intracytoplasmic mucin and/or the expression of TTF1 and/or napsin A.
-
The diagnostic criteria for AIS :
-
1.
Solitary, small tumor ≤3 cm.
-
2.
Purely lepidic growth pattern.
-
3.
No invasion: stromal, vascular, or pleural.
-
4.
No pattern of invasive ADC: acinar, papillary, micropapillary, solid, colloid, enteric, fetal, or invasive mucinous ADC.
-
5.
No spread through air spaces.
-
6.
Mainly nonmucinous cell type, rare mucinous .
-
7.
No or inconspicuous nuclear atypia.
-
8.
Septal widening with sclerosis/elastosis is common .
-
1.
-
The diagnostic criteria for MIA:
-
1.
Solitary, small tumor ≤3 cm.
-
2.
Predominantly lepidic growth pattern.
-
3.
≤0.5 cm invasive component in greatest dimension in any one focus.
-
4.
The invasive component to be measured includes any histologic subtype other than a lepidic pattern; tumor cells infiltrating myofibroblastic stroma.
-
5.
MIA diagnosis is excluded if the tumor invades lymphatics, blood vessels, air spaces, or pleura, contains tumor necrosis, and spreads through air spaces.
-
6.
The cell type is mostly nonmucinous, but rarely may be mucinous .
-
1.
-
The 2015 WHO classification of tumors of lung classifies ADC as lepidic, acinar, papillary, micropapillary, or solid according to the predominant pattern after a comprehensive histologic subtyping to identify all of the different histologic patterns in 5% increments.
-
Other variants of ADCs include invasive mucinous ADC, colloid ADC, fetal ADC, and enteric ADC.
-
Representative images are shown in Fig. 6.23a–d.
Immunohistochemistry
-
Positive for TTF1 and napsin A : commonly used markers for pneumocytes, with comparable sensitivity, about 75%; much lower TTF1 expression in solid ADCs and mucinous ADCs
-
Positive for CK7
-
Negative for squamous cell markers; however, p63 positivity was reported in up to 30% of lung ADCs.
-
Representative images are shown in Fig. 6.23e–h.
-
EGFR, Kirsten rat sarcoma viral oncogene (KRAS), and ALK mutations are specific for lung ADCs. The ADCs with EGFR or ALK alteration are usually located in the periphery; in contrast, the ADCs with KRAS mutation are frequently located in hilar region. The prevalence for KRAS and EGFR mutations is 10–30%; the transforming fusion gene echinoderm microtubule-associated protein-like 4 (EML4)-ALK is found in 5% of lung ADCs. The characteristics of patients with EGFR mutation are Asians, never smokers, with nonmucinous tumors; for ALK mutation, patients are younger age, male gender, and never or light smokers; for KRAS mutation patients are non-Asians, smokers, with invasive mucinous ADCs usually negative for TTF1 , and positive for mucin (MUC) 2,5,6 immunophenotypes .
Neuroendocrine Tumors
This group of tumor represents a morphologic and biologic spectrum of tumors that is classified by the 2015 WHO classification of tumors of the lung into four types: preinvasive lesion (including diffuse idiopathic pulmonary neuroendocrine cell hyperplasia ), carcinoid tumors (including typical and atypical carcinoid tumors ), large cell neuroendocrine carcinoma (LCNEC) , including combined LCNEC, and small cell carcinoma (including combined small cell carcinoma ).
Carcinoid Tumor
Carcinoid tumors are neuroendocrine epithelial malignancies, including typical carcinoids, defined as those with <2 mitoses/per 2 mm2, lacking necrosis, ≥0.5 cm in size, and atypical carcinoids, which are those with 2–10 mitoses/per 2 mm2 and/or foci of necrosis.
Key Clinical Features
-
Account for <1% of all lung cancers.
-
Majority (70–90%) are typical carcinoids.
-
More common in female, white, and <60 years old.
-
Clinical syndromes are uncommon, including carcinoid syndrome, Cushing syndrome, and acromegaly.
Key Radiographic Findings
-
Chest x-ray: usually a centrally located, lobulated mass with a prominent endobronchial component; one third of tumors in periphery.
-
CT using intravenous contrast medium shows considerable enhancement; calcification, especially in centrally located tumors; atelectasis; bronchiectasis; and hyperlucency for tumors with bronchial involvement.
Cytological Features
-
Loosely cohesive groups and single uniform cells with granular nuclei and ample eosinophilic cytoplasm and naked nuclei.
-
Round, columnar, or plasmacytoid cells, forming acinar or rosette-like structures.
-
Branching capillaries.
-
Clean background.
-
May show pleomorphism and prominent nucleoli in atypical carcinoids.
-
Mitoses uncommon, no necrosis in typical carcinoids; necrosis and mitosis seen in atypical carcinoids.
-
Representative images are shown in Fig. 6.24a, b.
Differential Diagnosis
-
Small cell carcinoma
-
Lymphoma
-
Benign bronchial epithelial cells
-
Mesenchymal tumor (spindle cell carcinoid)
-
ADC
Histology
-
Usually uniform polygonal or spindled cells arranged in organoid or trabecular patterns.
-
Other growth patterns also seen: rosette formation, papillary, pseudoglandular, or follicular patterns.
-
Significant pleomorphism and prominent nucleoli may be seen in typical carcinoids.
-
The differential features for atypical carcinoids are the presence of 2–10 mitoses per 2 mm2 and/or necrosis. These changes may be focal.
-
Representative images are shown in Fig. 6.24c–f.
Immunohistochemistry
-
Immunohistochemistry is recommended for the diagnosis of neuroendocrine tumors , not only in small biopsy or cytology cases but also in resected specimens.
-
The typical phenotype expresses neuroendocrine markers (CD56 , synaptophysin , chromogranin ); most are positive for panCK and negative for high molecular weight cytokeratins (HMWCKs) and TTF1 . However, TTF-1 expression was reported in 43–53% of cases.
-
The proliferative index (ki-67) is valuable in distinguishing carcinoids from high-grade neuroendocrine carcinomas, especially in small biopsies or cytology specimens with significant crush artifact. Small cell carcinomas have high proliferative index (>50%) in contrast to <10–20% in carcinoids.
-
Ki-67 is not recommended for the distinction of typical from atypical carcinoids due to the lack of cutoff value.
-
Representative images are shown in Fig. 6.25a–d.
Large Cell Neuroendocrine Carcinoma (LCNEC )
Key Clinical Features
-
Heavy smokers in >90% of cases.
-
Paraneoplastic syndrome is uncommon.
Key Radiological Findings
-
Usually a periphery mass with irregular margin, with or without intratumoral calcification
-
The tumors are usually large, showing central inhomogeneous enhancement on CT with contrast.
-
Cavitation uncommon
Cytological Features
-
Overlapping with other neuroendocrine tumors and ADCs
-
Loosely cohesive or single, monotonous tumor cells with a hyperchromatic nuclear chromatin pattern but easily appreciated nucleoli, nuclear membrane irregularity, and preserved moderate to abundant, delicate cytoplasm
-
Necrosis or apoptotic debris may be seen.
-
Representative images are shown in Fig. 6.26a, b.
Differential Diagnosis
-
Other neuroendocrine tumors , including small cell carcinoma
-
Other non-small cell carcinomas, such as ADC, basaloid squamous cell carcinoma , and large cell carcinoma
-
Melanoma
-
Metastasis
Histology
-
Usually arranged in typical neuroendocrine tumor growth patterns, such as organoid, trabecular, rosette-like, peripheral palisading, or solid patterns.
-
The tumor cells are often larger, with nucleoli (often prominent) and moderate to abundant cytoplasm.
-
Mitotic figures >10/per 2 mm2 (with an average of 75) of viable tumor; tumors with <30 mitoses/per 2 mm2 are rare.
-
The proliferative index (ki-67) is usually in the range of 40–80%.
-
Necrosis is common.
-
Representative images are shown in Fig. 6.26c, d.
Immunohistochemistry
-
Immunohistochemical markers such as synaptophysin , chromogranin , and CD56 are required to confirm neuroendocrine differentiation of the tumor.
-
CD56 was reported in 92–100% of cases, chromogranin in 80–85%, and synaptophysin in 50–60%.
-
About 50% of cases are positive for TTF1 .
-
PanCK, low molecular weight cytokeratin (LMWCK), and CK7 are expressed in either dot-like or diffuse cytoplasmic patterns.
-
CD117 positivity was reported in >70% of cases .
Small Cell Carcinoma
Key Clinical Features
-
Thirteen percent of all newly diagnosed lung cancers are small cell carcinomas.
-
Virtually all are heavy smokers, male predominant.
Key Radiological Findings
-
Usually a centrally located lobulated mass, with occasional endobrochial involvement; 5% peripherally located
-
A large hilar mass with bulky mediastinal lymph nodes is characteristic; invasion of hilar vessels and vena cava is common; cavitation is rare.
Cytological Features
-
Small cells with hyperchromatic nuclei, powdery chromatin texture, indistinct nucleoli, nuclear molding, and scant cytoplasm
-
Marked mitosis and single cell necrosis
-
Nuclear debris and crush artifact in the background
-
Representative images are shown in Fig. 6.27a–d.
Differential Diagnosis
-
Reserve cell hyperplasia
-
Carcinoids
-
Small blue cell tumors, such as lymphoma, Ewing sarcoma, and rhabdomyosarcoma
-
Non-small cell carcinoma
-
Pulmonary blastoma
-
Merkel cell carcinoma
Histology
-
The tumor usually presents in a sheetlike pattern.
-
The tumor cells are small, containing round, oval, or spindled nuclei, with a fine granular chromatin pattern, inconspicuous nucleoli, and scant cytoplasm, without defined cell borders.
-
Nuclear molding is frequent.
-
High mitotic rate is seen, at least 10 mitoses/per 2 mm2, with an average of 60 mitoses/per 2 mm2. The proliferative index (ki-67) is >50%, with an average of >80%.
-
May show extensive necrosis
-
Representative image is shown in Fig. 6.27e.
Immunohistochemistry
-
Immunohistochemical studies may be required to confirm neuroendocrine and epithelial differentiation of the tumor.
-
CK AE1/3, CAM5.2, and MNF116 are positive in nearly 100% of cases, with either dot-like, paranuclear, or diffuse cytoplasmic staining patterns.
-
Neuroendocrine markers (CD56 , synaptophysin , and chromogranin ) are reactive in the majority of cases; CD56 and synaptophysin are usually diffuse and strong, but chromogranin is often focal and weak.
-
<10% of small cell carcinomas may lack or have only very focal expression of neuroendocrine markers.
-
TTF1 is positive in up to 90–95% of cases.
-
CD117 positivity was reported in 60% of cases.
-
Representative images are shown in Fig. 6.27f–j.
The features of differential diagnosis for neuroendocrine tumors are summarized in Table 6.5.
Large Cell Carcinoma
Key Clinical Features
-
About 2.3% of all pulmonary malignancies.
-
Usually in the sixth decade, male predominant.
-
Most patients are smokers.
Key Radiographic Features
-
Chest x-ray: usually a peripheral mass, rarely may be cavitated
Cytological Features
-
Single cells or loose clusters
-
Vesicular, pleomorphic nuclei with irregular nuclear membrane, multiple nucleoli and high nuclear-to-cytoplasmic ratio
-
Ill-defined, feathery cytoplasm
Differential Diagnosis
-
Poorly differentiated non-small cell carcinoma
-
Melanoma
-
Metastatic carcinoma
-
Radiation reaction
-
Large cell non-Hodgkin lymphoma
-
Anaplastic lymphoma
-
Sarcoma
Histology
-
Large cell carcinoma can only be diagnosed in a resected specimen, after ruling out the presence of squamous cell carcinoma, ADC, and small cell carcinoma morphologically, immunohistochemical evidence of squamous or ADC differentiation, and mucin stain.
-
For small biopsy or cytology cases, large cell carcinomas can only be diagnosed as non-small cell lung carcinoma, not otherwise specified (NSCLC, NOS).
-
Composed of sheets or nests of polygonal cells with vesicular nuclei, prominent nucleoli, and moderate amounts of cytoplasm.
Immunohistochemistry
-
Immunohistochemical evaluation for TTF1 , p40 , and, if indicated, neuroendocrine markers (synaptophysin , chromogranin , and CD56 ) to exclude the presence of ADC, squamous cell carcinoma, and high-grade neuroendocrine carcinomas (small and large cell).
-
Only cases with negative phenotypes for those markers or cases with unclear patterns are classified as large cell carcinomas.
-
Three subtypes of large cell carcinomas are based on immunophenotype:
-
1.
Large cell carcinoma with null immunohistochemical features: mucin −; cytokeratin +; TTF1 −; p63 /p40 /CK5/6 −
-
2.
Large cell carcinoma with unclear immunohistochemical features: mucin −; cytokeratin +; TTF1 −; p63 /p40 /CK5/6 : any one of them showing focal +
-
3.
Large cell carcinoma with no additional stains: no immunohistochemical or mucin staining available
-
1.
-
Genomic data are limited to marker-null large cell carcinomas. The mutations found are those showing association with ADCs, such as KRAS and occasional EGFR. TP53 mutations, CDKN2A deletions, and MYC as well as cyclin E1 (CCNE1) amplifications are also reported, with a similar frequency to that of other histological types. Therefore, molecular testing is recommended for large cell carcinomas .
Sarcomatoid Carcinoma
Sarcomatoid carcinoma is a general term that includes pleomorphic carcinoma , carcinosarcoma , and pulmonary blastoma , which are individual entities in the 2015 WHO classification. This group of tumors accounts for 2–3% of all cancer cases in a surgical series and <1% of all lung cancers. Definitive diagnosis of this group of tumors is very difficult or impossible in small biopsies and cytology specimens.
The characteristic features of individual tumors in this group are summarized in Table 6.6.
Representative images are illustrated in Fig. 6.28a–h.
Nuclear Protein in Testis (NUT) Carcinoma
This is a new entity in the 2015 WHO classification of tumors of lung. The group of carcinomas associated with chromosomal rearrangement in the NUT gene is designated as NUT carcinoma.
Key Clinical Features
-
Affects people of all ages, although, it was originally reported in children and younger adults
-
Male equals female
-
Fewer than 100 cases reported
-
Usually presents at an advanced stage, with pleural effusion, chest pain, weight loss, and respiratory symptoms
Key Radiological Features
-
Chest x-ray: extremely rapid-growing tumor, with complete opacification of the thorax within 2–8 weeks
-
CT: a hypoattenuating, heterogeneously enhancing, often extensively necrotic mass with poorly defined, infiltrative borders. High fluorodeoxyglucose (FDG) uptake is characteristic.
Cytologic Findings
-
Usually cellular smears
-
Discohesive clusters and single of small to intermediate size, monomorphic cells with irregular nuclear membrane, granular to coarse chromatin pattern, and discrete nucleoli
-
Mitoses, necrotic debris, and crush artifact are common.
-
Representative image is shown in Fig. 6.29a.
Differential Diagnosis
-
Poorly differentiated malignant neoplasms
-
Basaloid squamous cell carcinoma
-
Small cell carcinoma
-
Ewing sarcoma
-
Germ cell tumor
-
Acute leukemia
Histology
-
NUT carcinoma, also known as NUT midline carcinoma
-
Usually composed of sheets and nests of small- to intermediate-size undifferentiated cells with a monomorphic appearance
-
The tumor cells are primitive-appearing, with irregular nuclear membrane, distinct nucleoli, granular to coarse chromatin, and pale eosinophilic to basophilic cytoplasm.
-
Neutrophil infiltration is a prominent feature.
-
Foci of abrupt keratinization are characteristic.
-
Representative image is shown in Fig. 6.29b.
Immunohistochemistry
-
Speckled nuclear positivity in more than 50% of tumor cells with NUT antibody is a constant finding and is diagnostic.
-
Broad-spectrum cytokeratins are positive in majority of cases.
-
Other epithelial markers, such as epithelial membrane antigen (EMA), epithelial cell adhesion molecule (BerEP4), and carcinoembryonic (CEA) antigen showed variable results.
-
Most of cases are positive for p63 /p40 and CD34.
-
Occasional reactivity to synaptophysin , chromogranin , and even TTF1 was observed.
-
NUT carcinomas are defined by the presence of NUT gene rearrangement, which is a chromosomal translocation between the NUT gene (NUTM1) on chromosome 15q14 and other genes: Bromodomain containing 4 (BRD4) on chromosome 19p13.1 (70%), BRD3 on chromosome 9q34.2 (6%), or an unknown partner gene (24%).
Metastasis to the Lung (See Chap. 7 on the Liver and Other Chapters)
The most common metastatic tumors are carcinomas, especially from the gastrointestinal tract, gynecological tract, breast, urothelial, head and neck, prostate, and other sites, followed by sarcomas, melanomas, and germ cell tumors . Sex and age distribution depend on tumor types, such as colorectal cancers in elderly patients of both sexes, breast cancer and melanoma in younger adults, and germ cell tumors and sarcomas in young adults or children. Metastases can be single or multiple, usually involving the lung parenchyma and the pleura. However, bilateral, multiple, peripherally located round, variable-size nodules (hematogenous metastases), or diffuse thickening of the interstitium (lymphangitic carcinomatosis) are typical.
Cytological features, histological findings, and immunoprofile are the same as the primary tumors. The differential immunophenotypes for the most common metastatic carcinomas are summarized in Table 6.7.
Pleura
The WHO classifications of tumors of the pleura, 2015, are summarized in Table 6.8.
Mesothelioma
Key Clinical Features
-
Usually occurs in older adults, ≥60 years
-
More often in men
-
A strong association with asbestos exposure
-
Pleural effusion is very common.
Key Radiological Features
-
Variety of presentations, classically exhibiting a diffuse circumferential ring of nodular pleura associated with ipsilateral effusion
-
Less commonly presents with pleural effusion without obvious pleural nodularity
-
Pleural plaques, especially associated with calcifications, are suggestive of asbestos exposure.
Cytological Features
-
Hypercellular specimen with mixed epithelial and spindle cells.
-
Can be epithelial or spindle cell dominate.
-
Resemble ordinary mesothelial cells.
-
Tumor giant cells, granulomas, and psammoma can be seen.
-
Representative images are shown in Fig. 6.30a–c.
Differential Diagnosis
Histology
Epithelioid Mesotheliomas
-
Account for 60–80% of malignant mesotheliomas
-
Variety of histological patterns. Most common patterns: solid, tubulopapillary, and trabecular; less common patterns: micropapillary, adenomatoid (microcystic), clear cell, transitional, deciduoid, and small cell
-
The tumor cells are usually bland, with eosinophilic cytoplasm and a bland vesicular chromatin pattern. Occasional anaplastic forms may be observed.
-
The fibrous stroma can vary from scant to prominent, showing varying degree of cellularity from hyalinized acellular to highly cellular stroma. Myxoid changes may be seen in 5–10% of cases, with nests of bland-looking, vacuolated epithelioid cells floating in the matrix.
-
Representative images are shown in Fig. 6.30d–f.
Sarcomatoid Mesotheliomas
-
Characterized by a proliferation of spindle cells arranged in fascicles or with a haphazard pattern and involves the adipose tissue of the parietal pleura or the adjacent lung parenchyma.
-
The tumor cells show variety of morphology, from plump to thin, elongated cells with scant cytoplasm.
-
The degree of nuclear atypia, mitotic activity, and necrosis vary from minimal to moderate to marked .
Desmoplastic Mesotheliomas
-
Characterized by areas of atypical spindle cells arranged in a so-called patternless pattern within a dense, hyalinized, fibrous stroma constituting at least 50% of the tumor
-
Invasion of adipose tissue is the most reliable criterion to distinguish desmoplastic mesothelioma from organizing pleuritis.
Biphasic Mesotheliomas
-
Show any combination of the patterns described above constituting at least 10% of the tumor
Immunohistochemistry
-
Positive for CK AE1/3, calretinin , CK5/6 , WT1, and D2–40.
-
Negative for BerEP4, MOC-31, B72.3, and CEA.
-
Multiple chromosomal alterations, more common with chromosomal losses, especially on chromosomal arms 1p, 3p, 4q, 6q, 9p, 13q, 14q, and 22q; alterations in several tumor suppressor genes, including neurofibromin 2 (NF2), CDKN2A (p16INK4a), CDKN2B (p15INK4b), and BRCA1-associated protein 1 (BAP1).
-
Representative images are shown in Fig. 6.31a–f.
Mesenchymal Tumors
Solitary Fibrous Tumor
Key Clinical Features
-
Most common in sixth to seventh decades
-
No sex predisposition
-
Accounting for <5% of primary pleural tumors
-
Unknown etiology
-
Slow-growing, relatively benign tumors, up to 10% malignant
-
Usually asymptomatic, incidental finding
Key Radiological Features
-
Usually solitary, well-circumscribed mass arising from visceral pleura
-
Can be multiple and distributed throughout the pleural cavity
Cytological Features
-
Cellular smear with bland-appearing, small, oval to spindled cells
-
No mitosis or necrosis
-
Representative images are shown in Fig. 6.32a, b.
Differential Diagnosis
-
Neuroendocrine tumors
-
Synovial sarcoma
-
Sarcomatoid mesothelioma
-
Nerve sheath tumor
-
Type A thymoma
Histology
-
Uniform fibroblastic spindle cells with tapering nuclei, scant, pale, indistinct cytoplasm, variable cellularity, and patternless architecture.
-
Focal storiform or fascicular growth pattern may be seen.
-
Prominent stromal and perivascular hyalinization.
-
Branching hemangiopericytoma-like vessels of varying size and number.
-
Usually <3 mitoses/per 2 mm2; malignant: > 4 mitoses/per 2 mm2, rarely showing dedifferentiation.
-
Representative images are shown in Fig. 6.32c, d.
Immunohistochemistry
-
Positive for signal transducer and activator of transcription 6 (STAT6): > 95% of cases, specific.
-
Positive for CD34, B-cell CLL/lymphoma 2 (Bcl2), and CD99: nonspecific.
-
Occasionally may be positive for SMA, epithelial membrane antigen (EMA), keratin, S100, or desmin.
-
Representative images are shown in Fig. 6.32e, f.
-
The tumor harbors characteristic gene fusion NGFI-A binding protein 2 (NAB2)-STAT6 .
Mediastinum
Overview
The mediastinum can be divided into four hypothetical compartments: superior, anterior, middle, and posterior. The distribution of organs and tumors of the mediastinum is summarized in Table 6.11.
In adults, the distribution of tumors is as follows: 46% thymic epithelial tumors, 23% lymphomas, 16% endocrine tumors, and 15% germ cell tumors . In children, the frequency of tumors is 47% neurogenic neoplasms, 19% germ cell tumors, 12% lymphomas, 10% thymic epithelial tumors, 6% cysts, and 6% mesenchymal tumors. The 2015 WHO classification of tumors of the thymus is summarized in Table 6.12.
Selected entities will be discussed in the section below.
Cysts
Key Clinical Features
-
Bronchogenic cyst –any part of the mediastinum
-
Enteric cyst – posterior mediastinum
-
Thymic cyst – anterior mediastinum
-
Pericardial cyst –middle mediastinum
Cytological Features
-
Hypocellular smear
-
Dependent upon the type of the cyst
Epithelial Tumors
Thymoma
Key Clinical Features
-
Rare malignancy overall, but the most common mediastinal tumors in adults
-
Median age of 50 years, rare in children
-
May present as a mass lesion or an incidental finding
-
May be associated with myasthenia gravis, pure red cell aplasia, hypogammaglobulinemia (Good syndrome), and/or other autoimmune disorders
Key Radiological Features
-
Usually a mass lesion, well-circumscribed or invasive borders, depending on the subtypes of thymoma
Cytological Features
-
Usually moderate to hypercellular smear
-
Two populations of relatively bland neoplastic epithelial cells and lymphocytes
-
The proportion of epithelial cells and lymphocytes is dependent upon subtype.
-
In epithelial subtype, epithelial cells are dominant; in lymphocyte-predominant subtype, small mature lymphocytes are dominant; and in spindle cell type, spindle epithelial cells are predominant.
-
Neoplastic epithelial cells tend to be cohesive and have a delicate nuclear membrane, fine nuclear chromatin, and small nucleoli.
-
Few or no mitoses are present.
-
Representative images are shown in Fig. 6.33a–f.
Differential Diagnosis
-
Thymic carcinoma
-
Thymic hyperplasia
-
T-cell lymphoblastic lymphoma
-
Neuroendocrine neoplasm
Histology
-
Type A thymoma:
-
1.
Complete or incomplete fibrous capsule may display coarse lobulation with thick fibrous bands.
-
2.
Microcystic pattern is most common, more prominent in subcapsular areas.
-
3.
Other patterns: rosettes (with or without a central lumen), glandular or glomeruloid structures, Masson’s hemangioma-like papillary projections in cystic spaces, meningioma-like whorls, fascicular growth, and storiform growth.
-
4.
Hassall corpuscles are absent.
-
5.
The tumor cells are spindled and/or oval-shaped with bland nuclei, finely dispersed powdery chromatin, and inconspicuous nucleoli.
-
6.
Low mitotic activity, usually <4 mitoses/per 2 mm2.
-
7.
No or very few immature lymphocytes.
-
8.
When hypercellularity, increased mitotic counts, and focal necrosis are present, designate as atypical type A thymoma variant.
-
9.
Representative images are shown in Fig. 6.34a, b.
-
1.
-
Type AB thymoma:
-
1.
Well-demarcated and encapsulated tumor showing a lobulated growth pattern.
-
2.
Highly variable mixture of a lymphocyte-poor type A component and a more lymphocyte-rich type B-like component including a prominent infiltrate (often in dense clusters) of immature, TdT + T cells. Infiltrate of TdT+ lymphocytes in >10% of the tumor area is a feature used to distinguish from type A thymoma.
-
3.
The tumor cells are small, oval to plump, spindled, or polygonal shaped, containing round to oval pale-staining nuclei showing dispersed chromatin and inconspicuous nucleoli.
-
4.
Medullary islands are very rare; Hassall corpuscles are absent.
-
5.
Summary of three distinctive features of type AB thymoma: (a) an admixed spindle cell-predominant, lymphocyte-poor component and lymphocyte-rich component; (b) bland, spindly, oval, and focally polygonal thymic epithelial cells; and (c) a focal or diffuse abundance of immature T cells .
-
1.
-
Type B1 thymoma :
-
1.
Thymus-like architecture with predominance of cortical areas.
-
2.
Either absence of lobulation or lobulated with larger lobules traversed by hypocellular, collagenous septa.
-
3.
The neoplastic epithelial cells are individually embedded in densely packed nonneoplastic immature lymphocytes; the epithelial cells have poorly defined, pale eosinophilic cytoplasm, and relatively uniform, oval to slightly irregular round nuclei, showing pale chromatin, distinct nuclear membranes, and small central nucleoli.
-
4.
Medullary islands are always present and may contain Hassall corpuscles and myoid cells; perivascular spaces are often seen.
-
5.
Summary of two distinctive features of type B1 thymoma: (a) close resemblance to the normal, non-involuted thymic cortex; (b) the consistent presence of medullary islands.
-
6.
Representative images are shown in Fig. 6.34c, d.
-
1.
-
Type B2 thymoma :
-
1.
Encapsulated tumor, composed of lymphocyte- predominant, irregular size and shape tumor lobules surrounded by delicate fibrous septa, giving a lobular architecture and blue appearance on hematoxylin and eosin (H&E) stain.
-
2.
Interspersed among the lymphoid cells are single or poorly defined clusters of epithelial cells (≥ 3 cells).
-
3.
The epithelial cells have round or slightly oval nuclei with vesicular chromatin and small but prominent nucleoli; rare focal anaplasia may be seen.
-
4.
Perivascular spaces composed of a central venule surrounded by a clear space containing proteinaceous fluid or lymphocytes.
-
5.
Hassall corpuscles are rare; medullary islands are uncommon.
-
6.
Summary of distinctive features of type B2 thymoma: (a) polygonal (non-spindle shaped) neoplastic thymic epithelial cells in clusters; (b) high content of intermingled immature T cells .
-
1.
-
Type B3 thymoma :
-
1.
Tumor lobules separated by fibrous septa, pushing borders at the invasion front, prominent perivascular spaces with epithelial palisading, rare Hassall corpuscles.
-
2.
Tumor cells are polygonal with eosinophilic or clear cytoplasm and slightly/moderately atypical, round to elongated, grooved, or raisinoid nuclei.
-
3.
Summary of distinctive features of type B3 thymoma: (a) predominance of polygonal epithelial cells forming solid sheets, resulting in a pink appearance on H&E; (b) paucity of admixed nonneoplastic immature T cells .
-
1.
Immunohistochemistry
-
Epithelial cells: usually positive for AE1/3, CK7 , CK19, p63 , PAX8 , forkhead box N1 (FOXN1), CD57, and CD205; negative for EMA, CD117 , and CD5 .
-
Small lymphocytes (thymocytes) are mature T-cells, but positive for CD3, CD5 , TdT , CD99, with a high MIB1 (Ki-67) proliferative index.
-
Representative images are shown in Fig. 6.34e–h.
Thymic Carcinomas
Thymic carcinomas include of a variety of histological types of tumors, accounting for approximately 22% of all thymic epithelial neoplasms. The squamous cell carcinomas are the most common type, accounting for approximately 70% of all thymic carcinoma cases. Lymphoepithelioma-like carcinomas are rare, accounting for 6–32% of all thymic carcinomas; sarcomatoid carcinomas account for 5–10%; and basaloid carcinomas account for <5%. Other types, such as mucoepidermoid carcinomas , clear cell carcinomas, ADCs, NUT carcinomas, and undifferentiated carcinomas, are very few. The characteristic features of the three most common types are summarized in Table 6.13.
Thymic Neuroendocrine Tumors
Thymic neuroendocrine tumors are categorized into two major groups: (1) low-grade typical carcinoids and intermediate-grade atypical carcinoids, which always show characteristic morphological and immunohistochemical neuroendocrine features, and (2) high-grade LCNECs and small cell carcinomas, which may lack some neuroendocrine features.
Key Clinical Features
-
No established association with smoking.
-
More aggressive clinical course: propensity for recurrence, lymph node or distant metastases, and tumor-associated death.
-
Atypical carcinoids account for the majority of the tumors.
-
Only carcinoids reported in setting of multiple endocrine neoplasia type 1 (MEN1).
-
Average age at presentation: 49 years.
-
Carcinoids show a strong male predominance .
Key Radiological Features
-
Typically a lobulated, heterogeneous mass in the anterior mediastinum
Cytological Features
-
Same as pulmonary neuroendocrine tumors ; please refer that section in this chapter.
-
Representative images are shown in Fig. 6.36a–i.
Differential Diagnosis
-
Pulmonary neuroendocrine tumors : careful clinical and radiological correlation is the primary way to distinguish pulmonary from thymic neuroendocrine tumors.
-
Thymoma, especially type A, to distinguish from carcinoids.
-
Thymic carcinoma usually shows focal and/or weak expression of neuroendocrine markers.
Histology
The same as pulmonary neuroendocrine tumors , respectively.
Immunohistochemistry
Same as the pulmonary neuroendocrine tumors , respectively .
Germ Cell Tumors of the Mediastinum
Key Clinical Features
-
Accounts for 3–4% of all germ cell tumors ; up to 16% of all mediastinal tumors
-
In prepubertal patients (mean <8 years): teratomas (58%), yolk sac tumors +/− teratoma (42%)
-
In postpubertal female patients: teratoma (93%), seminoma (dysgerminoma) (4%), embryonal carcinoma (2%), and others (<1%)
-
In postpubertal male patients (mean 25–29 years): teratoma (35%), seminoma (32%), mixed (16%), yolk sac tumor (10%), embryonal carcinoma (4%), and choriocarcinoma (3%)
-
In patients with Klinefelter syndrome: mediastinal non-seminomatous germ cell tumors particularly common but not seminomas or testicular germ cell tumors
-
Depending on tumor type, may have increased serum levels of the β-subunit of human chorionic gonadotropin (βhCG), α-fetoprotein (AFP), and lactate dehydrogenase
Key Radiological Features
-
Anterior mediastinal mass: uncalcified and homogeneous for seminomas, heterogeneous with central attenuation, and a frond-like periphery for non-seminomatous germ cell tumors .
-
Multilocular cystic lesions can accompany any type of mediastinal germ cell tumor (particularly seminomas), also others, such as thymomas, thymic carcinomas, Hodgkin or non-Hodgkin lymphomas, and metastases .
Cytological Features
-
Seminomas :
-
1.
Highly cellular smears composed of small loose syncytium-like clusters or isolated large tumor cells with centrally located round nuclei containing one or more prominent, irregular nucleoli, and clear to granular cytoplasm.
-
2.
Mitoses present.
-
3.
Admixed with polymorphous lymphocytes, occasional epithelioid histiocytes.
-
4.
A characteristic tigroid background.
-
5.
Representative images are shown in Fig. 6.37a–h.
-
1.
-
Embryonal carcinomas :
-
1.
Highly cellular smears
-
2.
Three-dimensional clusters or sheets of large, pleomorphic tumor cells with high nuclear-to-cytoplasmic ratio, irregular nuclear contours, coarse chromatin, and several nucleoli
-
3.
Indistinct pale cytoplasm
-
4.
Bizarre-shaped cells, mitoses, and necrosis frequent
-
1.
-
Yolk sac tumors :
-
1.
Clusters of medium to large pleomorphic tumor cells with irregular nuclear contours, vesicular nuclei, prominent nucleoli, and eosinophilic or vacuolated cytoplasm.
-
2.
Some tumor cells contain intracytoplasmic dense hyaline globules.
-
3.
Granular debris and mucoid or metachromatic material in background.
-
4.
No lymphocytes or epithelioid histiocytes .
-
1.
-
Choriocarcinomas :
-
1.
Cellular smears
-
2.
Malignant cytotrophoblasts: mononucleated, medium-size cells with vacuolated, basophilic cytoplasm, and eccentric nuclei
-
3.
Malignant syncytiotrophoblasts: very large tumor cells with one or several nuclei, distinct nucleoli, and eosinophilic cytoplasm
-
4.
Atypical mitoses
-
5.
Significant hemorrhage and necrosis in the background
-
1.
-
Teratoma :
-
1.
Mature teratoma: cytology diagnosis is difficult; may be paucicellular with few anucleated squamous cells and macrophages in a proteinaceous background; ciliated bronchial cells, smooth muscle, and cartilage are present; a mucoid background with bland-looking signet ring cell-like mucus cells may be seen.
-
2.
Immature teratoma: may be cellular, composed of aggregates or individual small, round, hyperchromatic cells with high nuclear-to-cytoplasmic ratio, and inconspicuous nucleoli; rare rosettes with neuropils, rhabdomyoblasts, immature cartilage, and blastema-like stromal cells may be identified .
-
1.
Differential Diagnosis
-
Metastatic gonadal germ cell tumors
-
Metastatic carcinomas
-
Small round blue cell tumors
-
Sarcomas
Histology
-
Seminoma :
-
1.
Sheets, cords, or irregular lobules of monotonous, round to polygonal tumor cells with central nuclei, macronucleoli, and abundant clear to lightly eosinophilic cytoplasm.
-
2.
Delicate fibrous septa, with infiltrates of lymphocytes, may form germinal centers.
-
3.
Granulomatous reaction and fibrosis.
-
4.
Syncytiotrophoblastic cells may be scattered throughout .
-
Embryonal carcinoma :
-
1.
Sheets, tubules, and papillary structures of large polygonal or columnar cells with round to oval, vesicular, hyperchromatic nuclei containing one or multiple nucleoli and a moderate amount of cytoplasm.
-
2.
Numerous mitoses, apoptotic bodies, and coagulated necrosis are common.
-
3.
Scattered single or small clusters of syncytiotrophoblasts in one third of cases .
-
Yolk sac tumor :
-
1.
Various patterns: reticular-microcystic, spindle cell, solid, macrocystic, papillary, forming Schiller-Duval bodies, polyvesicular vitelline, glandular-alveolar, and hepatoid patterns.
-
2.
The tumor cells may be flat or columnar, with intracellular and extracellular hyaline globules, as well as basement membrane-like material deposition between the cells .
-
Choriocarcinoma :
-
1.
Two cell components, syncytiotrophoblasts and cytotrophoblasts, arranged in solid nests or sheets, occasionally in a villus-like arrangement.
-
2.
The syncytiotrophoblasts are large, vacuolated, multinucleated giant cells with dark eosinophilic cytoplasm.
-
3.
The cytotrophoblasts are uniform, medium-size, polygonal cells with abundant clear cytoplasm and distinct cytoplasmic borders.
-
4.
Hemorrhage and necrosis are frequently observed .
-
Teratoma :
-
1.
Mature teratoma: solid or multicystic; cysts may be filled with clear, keratinous, gelatinous, or mucinous material; cartilage, spicules of bone, patches of pigmented tissue, or brain tissue may be discernible; an admixture of ectoderm, endoderm, and mesoderm is seen, assembled in either a disorganized or organized pattern.
-
2.
Immature teratoma: the immature teratomatous elements are mostly cellular spindle mesenchymal components, but immature neural and epithelial elements can be seen; frequent mitoses; embryonic rhabdomyoblastic tissue, blastomatous tissue resembling embryonic kidney or lung, primitive neuroectodermal tumor (PNET), and other epithelial or mesenchymal malignant transformations can be seen .
Immunohistochemistry
The immunophenotypes of mediastinal germ cell tumors are summarized in Table 6.14.
Lymphomas of the Mediastinum
Primary Mediastinal Large B-Cell Lymphoma
Key Clinical Features
-
An aggressive large B-cell lymphoma, of putative thymic B-cell origin
-
Accounting for 2–3% of all non-Hodgkin lymphomas
-
Predominantly in young adults, third to fourth decades
-
Female predominance
-
No known risk factors
Key Radiographic Features
-
Anterior-superior mediastinal mass, often bulky, invading adjacent structures
-
The mass typically shows a regular contour.
Cytological Features
-
Atypical medial to large-size, monomorphic lymphoid cells with irregular, round to oval nuclei, small nucleoli and clear to eosinophilic cytoplasm
-
Background of lymphoglandular bodies and abundant necrosis
Differential Diagnosis
-
Diffuse large B-cell lymphoma
-
Hodgkin lymphoma
Histology
-
Diffuse, sheets, or clusters of medium to large, monomorphic tumor cells with irregular, round to oval nuclei, small nucleoli, and clear or eosinophilic cytoplasm; some cases show cells with pleomorphic nuclei and abundant amphophilic cytoplasm resembling Hodgkin lymphoma or non-lymphoid tumors.
-
Admixed, especially at the periphery, are reactive lymphocytes, macrophages, and granulocytes.
-
Distinct fibrosis to form irregular collagen bands dividing tumor into variable size compartments .
Immunohistochemistry
-
Express CD19, CD20, CD22, and CD79a.
-
Express PAX5, B-cell Oct-binding protein 1 (BOB1), OCT2, and PU.1.
-
Lack expression of immunoglobulin; CD10 is often negative.
-
CD30 expression in >80% of cases, but usually weak and heterogeneous.
-
Positive for interferon regulatory factor 4/multiple myeloma oncogene 1 (IRF4/MUM1) (75%), CD23 (70%), and variable to Bcl2 and Bcl6.
-
Positive for myelin and lymphocyte (MAL) antigen, CD54, CD95, tumor necrosis factor receptor 1 (TRAF1), p63 , and nuclear REL .
Other Types of Lymphomas
Refer to Chap. 4 on lymph nodes.
Abbreviations List
Abbreviation | Full Text |
---|---|
ADC | Adenocarcinoma |
AFP | Alpha-fetoprotein (α-fetoprotein) |
AIDS | Acquired immunodeficiency syndrome |
AIS | Adenocarcinoma in situ |
AKT | Protein kinase B |
ALCL | Anaplastic large cell lymphoma |
ALK | Anaplastic lymphoma kinase |
ATS | American Thoracic Society |
B72.3 | Tumor-associated glycoprotein (TAG)72 |
BAC | Bronchioloalveolar carcinoma |
BAP1 | BRCA1 associated protein 1 |
Bcl (Bcl2, Bcl6) | B-cell CLL/lymphoma 2, 6 |
BerEP4 | Epithelial cell adhesion molecule |
BOB1 | B-cell Oct-binding protein 1 |
BRD | Bromodomain containing (BRD3, BRD4) |
CA | Carcinoma |
CCNE1 | Cyclin E1 |
CD | Cluster of differentiation |
CDKN2 | Cyclin-dependent kinase inhibitor 2 (CDKN2A, CDKN2B) |
CEA | Carcinoembryonic antigen |
CHR | Chromogranin (table only) |
CK | Cytokeratin |
CREB1 | CAMP responsive element binding protein |
CT | Computed tomography |
CTNNB1 | Catenin beta 1 |
CUL3 | Cullen 3 |
DAD | Diffuse alveolar damage |
EBV | Epstein-Barr virus |
EGFR | Epithelial growth factor receptor |
EM | Electron microscopy |
EMA | Epithelial membrane antigen |
EML4 | Echinoderm microtubule-associated protein-like 4 |
ERS | European Respiratory Society |
EWSR1 | Ewing sarcoma break point region 1 |
F | Focal (table) |
FDG | fluorodeoxyglucose |
FGFR1 | Fibroblast growth factor receptor 1 |
FNA | Fine needle aspiration |
FOXN1 | Forkhead box N1 |
GATA3 | GATA binding protein 3 |
GI | Gastrointestinal |
GLUT1 | Glucose transporter 1 |
Gly3 | Glypican 3 |
GMS | Grocott’s methenamine silver |
GTF2I | General transcription factor IIi |
GYN | Gynecologic |
H&E | Hematoxylin and eosin |
HMB45 | Human melanoma black 45 |
HMGA2 | High-mobility group AT-hook 2 |
HMWCK | High molecular weight cytokeratin |
IASCL | International Association for the Study of Lung Cancer |
Ig | Immunoglobulin |
IHC | Immunohistochemistry (only in table) |
IMP3 | Insulin-like growth factor II messenger RNA protein |
IRF4 | Interferon regulatory factor 4 |
KEAP1 | Kelch-like ECH-associated protein 1 |
KIT | |
KRAS | Kirsten rat sarcoma viral oncogene |
LCNEC | Large cell neuroendocrine carcinoma |
LCNEM | Large cell carcinoma with neuroendocrine morphology (in table only) |
LeuM1 | Cluster of differentiation (CD)15 |
LG | Low grade (table only) |
LMWCK | Low molecular weight cytokeratin |
LPP | Lipoma preferred partner |
MAL | Myelin and lymphocyte |
MALT | Mucosa-associated lymphoid tissue |
MART1 | Melanoma antigen recognized by T cells |
MDM2 | Mouse double minute 2 homolog |
Med | Median (table) |
MEN1 | Multiple endocrine neoplasia type 1 |
Met UCA | Metastatic urothelial carcinoma |
MIA | Minimally invasive adenocarcinoma |
MIB1 | Mindbomb E3 ubiquitin protein ligase 1 |
MPNST | Malignant peripheral nerve sheath tumor |
MRI | Magnetic resonance imaging |
MSA | Muscle-specific actin |
MSM | Malignant spindle cell melanoma |
MUC | Mucin (e.g., MUC1) |
MUM1 | Multiple myeloma oncogene 1 |
N/C | Nuclear-to-cytoplasmic ratio |
NATB2 | NGFI-A binding protein 2 |
NE | Neuroendocrine |
NET | Neuroendocrine tumor |
NF2 | Neurofibromin 2 |
NFE2L2 | Nuclear factor, erythroid 2 like 2 |
NK | Natural killer |
NKX3.1 | NK3 homeobox 1 |
NOS | Not otherwise specified |
NOTCH1 | Notch (Drosophila) homolog 1 |
NSCC | Non-small cell carcinoma (in tables only) |
NSCLC | Non-small cell lung carcinoma |
NUT | Nuclear protein in testis |
OCT3/4 | Octamer-binding transcription factor 3/4 |
OT2 | |
Pap | Papanicolaou |
PAS | Periodic acid-Schiff |
PAX | Paired box gene (PAX5, PAX8) |
PEComa | Perivascular epithelioid cell tumor |
PEComatous | Perivascular epithelioid cell (PEC)omatous tumors |
PET | Positron emission tomography |
PNET | Primitive neuroectodermal tumor |
PU.1 | |
RB1 | Retinoblastoma 1 |
REL | |
RNA | Ribonucleic acid |
RT-PCR | Reverse transcription polymerase chain reaction |
S100P | Placental S100 |
SALL4 | Sal-like protein 4 |
SARS | Severe acute respiratory syndrome |
SARS-CoV | Severe acute respiratory syndrome caused by coronavirus (SARS coronavirus) |
SATB2 | Special AT-rich sequence-binding protein 2 |
SC | Sarcomatoid |
SCNC | Small cell neuroendocrine carcinoma |
SMA | Smooth muscle actin |
SOX | Sex-determining region Y box (SOX1, SOX10, etc.) |
spp. | Species (many) |
SqCC | Squamous cell carcinoma (in tables only) |
STAT6 | Signal transducer and activator of transcription 6 |
SYN | Synaptophysin |
TdT | Terminal deoxynucleotidyl transferase |
TP | Tumor protein (TP53, TP63) |
TRAF | Tumor necrosis factor receptor |
TTF1 | Thyroid transcription factor 1 |
WHO | World Health Organization |
WT1 | Wilms tumor 1 |
βhCG | B subunit of human chorionic gonadotropin |
Suggested Reading
Cytology/Fine Needle Aspiration
Bibbo M, Wilbur DC. Comprehensive cytopathology. 4th ed. Philadelphia: Elsevier, Saunders; 2015.
Cibas ES, Ducatman BS. Cytology: diagnostic principles and clinical correlates. 2nd ed. Philadelphia: Saunders; 2003.
DeMay RM. The art & science of cytopathology. 2nd ed. Chicago: American Society for Clinical Pathology (ASCP) Press; 2012.
Kaur G, Verma K. Fine needle aspiration cytology of metastatic urothelial carcinoma: study of seven cases with review of literature. J Cytol. 2012;29(2):116–20.
Vural C, Yildiz K, Çabuk D, Akgül A. Transthoracic fine-needle aspiration cytology of non-invasive, low-grade urothelial carcinoma with lung metastasis: a case report with review of the literature. J Cytol. 2015;32(2):132–5.
Histology
Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012;489(7417):519–25.
Franks TJ, Chong PY, Chui P, Galvin JR, Lourens RM, Reid AH, et al. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore. Hum Pathol. 2003;34(8):743–8.
Gokmen-Polar Y, Cano OD, Kesler KA, Loehrer PJ, Badve, S. NUT midline carcinomas in the thymic region. Mod Pathol. 2014;27(12):1649–56.
Gu J, Korteweg C. Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol. 2007;170(4):1136–47.
Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST, Leung CY, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003;361(9371):1773–8.
Suster S, Moran CA. Tumors of the lung and pleura. In: Fletcher CDM, editor. Diagnostic histopathology of tumors. 4th ed. Philadelphia: Saunders; 2013. p. 207–45.
Travis WD, Brambilla E, Burke AP, Marx A, Nicholson A. WHO classification of tumours of the lung, pleura, thymus and heart. Lyon: IARC; 2015a.
Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JH, Beasley MB, et al. WHO panel. The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification. J Thorac Oncol. 2015b;10(9):1243–60.
Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, et al. Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med. 2013a;137(5):668–84.
Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, et al. Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med. 2013b;137(5):685–705.
Tse GM, To KF, Chan PK, Lo AW, Ng KC, Wu A, et al. Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS). J Clin Pathol. 2004;57(3):260–5.
Ancillary Tests
Chang A, Amin A, Gabrielson E, Illei P, Roden RB, Sharma R, et al. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung. Am J Surg Pathol. 2012;36(10):1472–6.
Dupin E, Calloni G, Real C, Gonçalves-Trentin A, Le Douarin NM. Neural crest progenitors and stem cells. C R Biol. 2007;330(6–7):521–9.
Esheba GE, Longacre TA, Atkins KA, Higgins JP. Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations. Am J Surg Pathol. 2009;33(3):347–53.
Gershon TR, Oppenheimer O, Chin SS, Gerald WL. Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation. Neoplasia. 2005;7(6):575–84.
Gruver AM, Amin MB, Luthringer DJ, Westfall D, Arora K, Farver CF, et al. Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung. Arch Pathol Lab Med. 2012;136(11):1339–46.
Higgins JP, Kaygusuz G, Wang L, Montgomery K, Mason V, Zhu SX, et al. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Am J Surg Pathol. 2007;31(5):673–80.
Huang X, Saint-Jeannet JP. Induction of the neural crest and the opportunities of life on the edge. Dev Biol. 2004;275(1):1–11.
Kang Y, Pekmezci M, Folpe AL, Ersen A, Horvai AE. Diagnostic utility of SOX10 to distinguish malignant peripheral nerve sheath tumor from synovial sarcoma, including intraneural synovial sarcoma. Mod Pathol. 2014;27(1):55–61.
Kelsh RN. Sorting out Sox10 functions in neural crest development. BioEssays. 2006;28:788–98.
Lin F, Liu H. Unknown primary/undifferentiated neoplasm. In: Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZE, editors. Handbook of practical immunohistochemistry: frequently asked questions. 2nd ed. New York: Springer Science+Business Media; 2015. p. 119–63.
Liu H, Shi J, Prichard J, Gung Y, Lin F. Immunohistochemical evaluation of GATA-3 expression in ER-negative breast carcinomas. Am J Clin Pathol. 2014;141(5):648–55.
Liu H, Shi J, Wilkerson ML, Lin F. Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. Am J Clin Pathol. 2012;138(1):57–64.
Miettinen M, PA MC, Sarlomo-Rikala M, Biernat W, Czapiewski P, Kopczynski J, et al. Sox10-a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors. Am J Surg Pathol. 2015;39(6):826–35.
Nonaka D, Chiriboga L, Rubin BP. Sox10: a pan-schwannian and melanocytic marker. Am J Surg Pathol. 2008;32(9):1291–8.
Ordóñez NG. Value of GATA3 immunostaining in tumor diagnosis: a review. Adv Anat Pathol. 2013a;20(5):352–60.
Ordóñez NG. Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update. Hum Pathol. 2014;45(2):191–205.
Ordóñez NG. Value of SOX10 immunostaining in tumor diagnosis. Adv Anat Pathol. 2013b;20(4):275–83.
Paratore C, Goerich DE, Suter U, Wegner M, Sommer L. Survival and glial fate acquisition of neural crest cells are regulated by an interplay between the transcription factor Sox10 and extrinsic combinatorial signaling. Development. 2001;128:3949–61.
Wilkerson ML, Cheng L. Urinary bladder and urachus. In: Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZE, editors. Handbook of practical immunohistochemistry: frequently asked questions. 2nd ed. New York: Springer Science+Business Media; 2015. p. 421–37.
Wilkerson ML, Lin F, Liu H, Cheng L. The application of immunohistochemical biomarkers in urologic surgical pathology. Arch Pathol Lab Med. 2014;138(12):1643–65.
Yang GG, Minasyan A, Gordon J, Lacey M, Lundquist K. Rabbit polyclonal anti-SOX10 is a reliable IHC marker for melanoma and its mimics [abstract]. Mod Pathol. 2013;26(S2):124A–5A.
Zhang K, Deng H, Cagle PT. Pleuropulmonary and mediastinal neoplasms. In: Lin F, Prichard JW, Liu H, Wilkerson M, Chen ZE, editors. Handbook of practical immunohistochemistry: frequently asked questions. 2nd ed. New York: Springer Science+Business Media; 2015. p. 313–41.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Liu, H., Zhang, J., Lin, F. (2018). Lung and Mediastinum. In: Handbook of Practical Fine Needle Aspiration and Small Tissue Biopsies. Springer, Cham. https://doi.org/10.1007/978-3-319-57386-1_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-57386-1_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-57384-7
Online ISBN: 978-3-319-57386-1
eBook Packages: MedicineMedicine (R0)